Access to Paediatric Health Information

This service maps and analyses the European landscape of authorised paediatric health interventions, technologies, and approaches to inform unmet medical needs and guide new clinical research strategies. Outputs include:

i) a comprehensive report of paediatric health solutions to identify gaps and unmet needs;

ii) a pipeline analysis report translating off-label practices and gaps into R&D opportunities, interventions, and proposals for repositioning existing medicines;

iii) full access to European Paediatric Marketed Medicines (EPMD) as the central reference for EU-authorised paediatric medicines; and

iv) HTA and Market Access analyses to support value demonstration, prioritisation, and decision-making.